ArticleJournal of Cancer2023
Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer.
Weike Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleJournal of Cancer2023
Weike Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.